Update shared on28 Aug 2025
Fair value Increased 2.78%The upward revision in Quaker Chemical’s consensus price target reflects a minor increase in forecasted future P/E ratio, while valuation inputs like the discount rate remain stable, resulting in a fair value target rising to $155.40.
What's in the News
- Reported an $88.8 million goodwill impairment charge related to the EMEA segment, resulting in a quarterly net loss.
- Completed a share buyback program, repurchasing 609,110 shares (3.42% of shares outstanding) for $81.94 million.
- Issued 2025 earnings guidance: expects 2025 revenue and earnings in line with 2024 amid tepid economic conditions; targeting $20 million in run-rate cost savings by end of 2026.
- Increased quarterly cash dividend by 4.7% to $0.508 per share.
- Removed from several Russell Growth indices and added to multiple Russell Value indices, reflecting a shift in index classification.
Valuation Changes
Summary of Valuation Changes for Quaker Chemical
- The Consensus Analyst Price Target has risen slightly from $151.20 to $155.40.
- The Future P/E for Quaker Chemical has risen slightly from 5.73x to 5.89x.
- The Discount Rate for Quaker Chemical remained effectively unchanged, moving only marginally from 8.02% to 8.03%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.